News Features Year in Review: Physicians Pick the Biggest News of 2016, in Interventional Cardiology and Beyond Shelley Wood December 30, 2016
News Features Repaso del Año: Los Médicos Eligen las Noticias Más Importantes de 2016 en Cardiología Intervencionista y Más Shelley Wood December 30, 2016
News Conference News AHA 2016 AHA 2016: Back to the Bayou for Functional Tests, NSAIDs, and Intermediate-Risk TAVR Shelley Wood November 09, 2016
News Opinion Editor's Corner TCT 2016 My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway Shelley Wood November 07, 2016
News Opinion Editor's Corner TCT 2016 Con Qué Me Quedo de TCT 2016: Sorpresas, Presuposiciones y Revelaciones Shelley Wood November 07, 2016
News Conference News TCT 2016 COLOR: PCI of Lipid-Rich Plaque Not Associated With Increased Risk of Adverse Events Michael O'Riordan November 01, 2016
Presentation TCT 2016 If You Do Image, Which Is The Tool For BRS - IVUS, HD-IVUS, Or OCT? Presenter: Jonathan M. Hill, Christoph K. Naber, Carlo Di Mario November 01, 2016
Presentation TCT 2016 TCT 548: Relationship Between Residual SYNTAX Score, Grayscale and Virtual Histology-IVUS Findings, and Non-Culprit Lesion-Related Major Adverse Cardiac Events: The PROSPECT Study Presenter: Eric Boersma, James E. Muller November 01, 2016
Presentation TCT 2016 Parallel Wires and Antegrade IVUS Guided Re-entry Presenter: William L. Lombardi, Etsuo Tsuchikane, Gerald S. Werner October 31, 2016
Presentation TCT 2016 TCT 1490: Use of Near Infra-Red Spectroscopy With IVUS to Confirm Coronary Vasospasm as a Cause of ACS Presenter: Jonathan M. Tobis, Giora Weisz, Nilesh Pareek October 31, 2016
Presentation TCT 2016 TCT 1272: T Modified Bifurcation Technique Guided by IVUS for Left Main Bifurcation Presenter: Emmanouil S. Brilakis, Ricardo A. Costa, Alexandre Zago October 31, 2016
News Industry News TCT 2016 First Report Investigations Examine Potential For Novel Bioresorbable Stent Technologies October 31, 2016
Presentation TCT 2016 FUTURE-I: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Bo Xu October 31, 2016
Presentation TCT 2016 MeRes-1: Six-Month Clinical, Angiographic, IVUS, and OCT Results With a Thin-Strut PLLA-Based Sirolimus-Eluting Bioresorbable Vascular Scaffold in Patients With Coronary Artery Disease Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Ashok Seth October 31, 2016
Presentation TCT 2016 REVELUTION: Nine-Month Clinical, Angiographic, IVUS, and OCT Outcomes With a Polymer-Free Sirolimus-Eluting Drug-Filled Stent Presenter: Patrick W. Serruys, Joanna J. Wykrzykowska, Stephen G. Worthley October 31, 2016
News Conference News TCT 2016 ‘Encouraging’ Preliminary Results Seen With Novel, Polymer-Free, Drug-Filled Stent Todd Neale October 31, 2016
News Conference News TCT 2016 BIONICS: Ridaforolimus-Eluting Stent Noninferior to Zotarolimus Stent at 1 Year TCT Daily Staff October 30, 2016
Presentation TCT 2016 Canada Presents: Role of IVUS, OCT and FFR in the Assessment of LM Stenosis, and PCI Guidance Presenter: Thomas Engstroem, Hyo-Soo Kim, Samer Mansour, Quang Ngoc Nguyen, Jean-Michel Paradis October 30, 2016